| Trial registration number
|
EUCTR2020-001610-38-DK |
Full text link
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001610-38/DK
|
First author
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
Not reported
|
Contact
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
Not reported
|
Registration date
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
2020-04-07
|
Recruitment status
Last imported at : June 1, 2023, 8 a.m.
Source : EU Clinical Trials Register
|
Completed
|
Study design
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
RCT
|
Allocation
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
Randomized
|
Design
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
Parallel
|
Masking
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
Blind label
|
Center
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
single-center
|
Study aim
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
Treatment
|
Inclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
Patients age 50-89 years and Covid-19 positiv and home.
Patienter der er testet positive for COVID-19. Alder: 50-89 år og er i hjemmekarantæne
|
Exclusion criteria
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
Actual treatment with ACE-inhibitor, AT-II receptor antagonist or diuretics
Blood pressure below 110/60
Pregnancy
Allergy to Irbesartan or Oseltamivir
Eksklusionskriterier for patienter: Patienter ekskluderes, hvis de er:
I behandling med ACE-hæmmer, ATII-antagonist eller diuretika
Blodtryk <110/60
Overfølsomme overfor Irbesartan eller Oseltamivir.
Gravide
|
Number of arms
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
2
|
Funding
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
Slagelse Sygehus
|
Inclusion age min
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
50
|
Inclusion age max
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
89
|
Countries
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
Denmark
|
Type of patients
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
Mild disease at enrollment
|
Severity scale
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
1: Mild disease at enrollment
|
Total sample size
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
80
|
primary outcome
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
Preventing patients with Covid-19 infection treated at home in hospitalizing for this diseace.
At hindre patienter med Covid-19 infektion i at få sygdomsprogression medførende indlæggelse.
|
Notes
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
nan
|
Phase
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
Phase 4
|
Arms
Last imported at : Oct. 26, 2020, 7:26 a.m.
Source : EU Clinical Trials Register
|
[{"arm_notes": "", "treatment_id": 1659, "treatment_name": "Irbesartan+oseltamivir", "treatment_type": "Cardiovascular agents+antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|